PPT-A Project Financier's Standpoint |Risk Assessment in IPF|

Risk Assessment in IPF 19 th May 2014 Project amp Structured Finance Investment Banking Group P r e s e n t a t i o n UNITED BANK LIMITED Note Please note that the following slides contain information on. – . The need for early recognition and referral. PRC-2128. It can be difficult to separate idiopathic pulmonary fibrosis (IPF) from other conditions. IPF is a rare but fatal lung disease, with a lower survival rate than many common malignancies. Dr. Abdelhaleem Bella. Assistant Professor of Medicine, Dammam University. Consultant Pulmonologist ,King Fahad Hospital of the University.. Layout of the Presentation. DPLD : A&C . ILD. IIP IPF. Overview of IPF. Overview of IPF (cont). The Role of HRCT in Assessing IPF. HRCT Techniques. Early HRCT Findings in IPF. Hypersensitivity Pneumonitis. HRCT Features and Distribution in Lungs. Definite UIP (All 4 Features). Jeffrey L. . Hartzell. , M.D.. 26 April 2015. Bio. NorthWood. High School (Nappanee, IN). DePauw University. Indiana University School of Medicine. University of Florida . Andrews Sports Medicine and . PULMONARY FIBROSIS MANAGEMENT STRATEGIES I. NOVEMBER 13, 2015. Managing comorbidity. Disclosures. . Scientific Advisory Board and speaker’s fees. Biogen. Idec, . Boehringer. . Ingelheim. ,. Gilead, . PULMONARY FIBROSIS MANAGEMENT STRATEGIES I. NOVEMBER 13, 2015. Pharmacologic therapy. Disclosures. Research Grants. Roche (. InterMune. ). Scientific Advisory Board . Roche (. InterMune. ). Boehringer. Dr. Holly Kruse. Communication Theory. Standpoint Theory. What is a “standpoint”?. B. ased on knowledge we gain from everyday life (“situated knowledge” based in context & circumstance).. – . The need for early recognition and referral. PRC-2128. It can be difficult to separate idiopathic pulmonary fibrosis (IPF) from other conditions. IPF is a rare but fatal lung disease, with a lower survival rate than many common malignancies. Discussing Prognosis &. Goals of Care. Sonye K. . Danoff. , MD, . PhD. PULMONARY FIBROSIS. : WHAT AND . WHY. November 13, 2015. No conflict of interest relevant to this presentation. Objective of this talk. IMRE NOTH, MD. CLINICAL CARE: NEW AND EVOLVING TREATMENT STRATEGIES . NOVEMBER 14, 2015. What is “Precision” Medicine?. Precision medicine. is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person.. 56-year-old Hispanic female with a family history of aortic aneurysm underwent a routine chest CT to assess her aorta. No respiratory symptoms. Medical history . h/o SVT. Type 2 diabetes mellitus. Hypertension. IPF. S2k-Leitline basiert. Präsentation im Rahmen von AT8 Ausbildung Mai 2019. . I. diopathische. . p. ulmonale . F. ibrose. . was ist das eigentlich?. Langsam fortschreitende Erkrankung des Lungeninterstitiums. A tool to support the infrastructure planning process. Darwin Marcelo. Sr. Infrastructure economist, . Infrastructure, PPPs and Guarantees Group. The World Bank . March 2019. 1. Infrastructure gap and demands on governments. A Project Financier's Standpoint |Risk Assessment in IPF| 19th May, 2014 |Project & Structured Finance|Investment Banking Group| |P r e s e n t a t i o n| |UNITED BANK LIMITED| Note Please note that the following slides contain information